Topics
Sector
Geography
Subject

Videos Library

All Videos

1227
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

The NextLevel LifeSciences Videos Library is the full collection of video recordings (and supporting documentation) from all NextLevel LifeSciences events.

Latest Videos

Presentation

“Value communication during pathway disruption” : The opportunity and challenge of disruptive medicine including CAR-T & Gene Therapy

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Defining pathway disruption
  • Challenges of value measurement
  • Market Access and Real World Evidence solutions to overcome challenges
Speaker

Amanda Pulfer
Managing Director
PH Associates

Presentation

Real World Evidence Opportunities in Medical Affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Areas of opportunity
  • Main hurdles
  • Elegant method to answer new questions with existing data
  • Methodology – bias and confounding
  • Opportunity for strategic partnership
  • Value for money
Speaker

Torkild Stenbock
General Manager
LINK Medical Research, Norway

Presentation

Patient Centricity in Non-Interventional Real-world Evidence Study Programs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Patient-Centricity & Care
Availability: FREE
  • Existing data sources as unique tools for study program pre-evaluation
  • Unique patient centric methodology to answer new questions
  • Patient centric, active surveillance methodology as a tool for in-depth validation of special medial outcome events
  • Classical non-interventional study approaches to complement the holistic view on the patient
Speaker

Marc Pignot
Director Real World Research Consulting
Kantar Health, Germany

Presentation

Biopharmaceutical Acceleration Model for Product Development & Commercialization

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
  • Outlining how, historically, product development has largely been disengaged from commercialization
  • Exploring how, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • Describing and  illustrating with a case study the  benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization,  involving comprehensive evidence development to meet clinical, regulatory and commercial needs
Speaker

Erwin De Cock
Principal, Real-World & Late Phase
Syneos Health

Presentation

A cigar is just a cigar...or is it?: Turbocharging MSL Communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology, Medical Science Liaison
Availability: FREE

Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.

Speaker

Pamela Peters
Szenior Director, Medical Affairs Strategic Solutions
Medscape

Presentation

The value of digital communications in medical affairs – practical and compliance considerations

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Gemma Allen
Senior Digital Communications Lead
Succinct Medical Communications

Presentation

Metrics to meaning: Measuring the success of medical communications in a digital airspace

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology, Capabilities & Effectiveness
Availability: FREE
  • The importance of metrics to demonstrate value and impact of communication programmes
  • From reach and engagement to behavioural metrics
  • Practical approaches to implementing metrics
Speakers

Robert Poole
Director of Scientific Services
Complete HealthVizion

Stephen Allison
Business Development Director
Complete HealthVizion, UK

Presentation

Leveraging Online Discussion Platforms for Optimal Stakeholder Engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement
  • Learn about innovative communication solutions that leading organizations are utilizing to overcome these challenges
  • Discuss the use of these solutions in delivering improved engagement outcomes, while remaining regulatory compliant
Speaker

Lance Hill
CEO
Within3

Presentation

Systematic Value Generation and Claim Prioritization based on Economic Impact

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Discover the relevant claim space for your target customer
  • Assess value and regulatory implications for aspired economic claims
  • Building a claim portfolio on differentiating impact before and after product launch
Speakers

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands

Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands

Presentation

The best buyer experience wins - How to use digital to leave a mark with the empowered buyer?

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Empowered buyer teams force Marketing & Sales to step up their game.
  • Marketing can support sales teams to become more solution-centric.
  • Sales teams can go beyond the expected and impact the modern-day buyer.
  • Ceterix, bioMérieux and ARGEN use sales enablement technology to step change Marketing and Sales alignment and grow sales productivity.
Speaker

Ellen Atkinson
Account Executive
Showpad

Presentation

Value-Based Procurement: differentiating with Value

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Moving the perspective from price to cost
  • Quantifying value in procurement
  • Case example: from lower cost to best option
  • Moving forward: role of the industry
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Customer-Centric Business Models: Where to start and How to Deliver?

Related topics: MedTech, Commercial
Availability: FREE
A perspective of the customer insight specialists on developing customer-centric business models
Key areas:
  • Role of Customer Insights in developing customer-centric business models
  • What are the different ways of approaching customer-centric pain points and unmet needs
  • How to distill impactful customer needs from customer wishlist
  • How to develop and validate business models through customer insights 
Speakers

Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, USA

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands

Presentation

Med Tech companies transform from “suppliers” to “partners”. What’s next? Opportunities for new sources of value

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Technology disruption: Non-healthcare players entering the market. Impact on our business model?
  • Technology-enabled care delivery: How do data, analytics and machine learning offer opportunities to address emerging payer and provider needs?
  • Reimaging the future state of med tech innovation: What kind of capabilities do we need to capture these new sources of value?
  • The case of diabetes management: Data at the center.
Speaker

Sotiris Rompas
Director, Life Sciences
Huron Consulting, USA

Presentation

Get the backing from the C-Suite: how to demonstrate ROI on your digital investments

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Understand how to turn the C-Suite into digital advocates 
  • Experience how the first movers in medtech have proven digital technology ROI
  • See how you can use your digital investments to enable better customer experiences for payers and HCPs
  • Explore how digital technology supports a key account strategy
  • Learn how to get it right: start small and scale fast 
Speaker

Lars Meincke
Chief Commercial Officer
Agnitio, Denmark

Presentation

Data and strategic perspective

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Anthony Page
CEO
Voxx Analytics

Presentation

A cigar is just a cigar...or is it?: Turbocharging MSL Communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE

Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.

Speaker

Pamela Peters
Senior Director, Medical Affairs Strategic Solutions
Medscape

Presentation

Futureproofing the Medical Affairs function in your organization

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker

William Soliman
President & CEO
Accreditation Council for Medical Affairs 

Presentation

Medical Affairs holds the reins in quality based medicine

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

No longer is the patient expected to be a silent bystander in the healthcare process. Increasingly, the patient stands at center stage, surrounded by healthcare providers, payers, educators, and other players.  This new patient-centricity—so crucial to quality healthcare—elevates the role of COMMUNICATION in the pharmaceutical industry. COMMUNICATION—between physician and patient, between pharmaceutical company and physician, between pharma and external regulators, and more —  and, as the hub of all that COMMUNICATION, Medical Affairs holds the reins to success, providing added-value to both internal and external stakeholders . This session will examine the factors that foster effective COMMUNICATION, both externally and internally,  and will provide data-driven case-based insights and examples.

Speaker

Pamela Peters
Senior Director, Medical Affairs Strategic Solutions
Medscape

Presentation

Leveraging online discussion platforms for optimal stakeholder engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement
  • Learn about innovative communication solutions that leading organizations are utilizing to overcome these challenges
  • Discuss the use of these solutions in delivering improved engagement outcomes, while remaining regulatory compliant
Speakers

Michael Kirby
Vice President, Business Partnerships,
Within3

Robert Honigberg
Sr. Medical Director, Medical Affairs
Flexion Therapeutics

Presentation

How to achieve effective medical communication and also optimize field force: A Revolutionary Approach for KOL mapping

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
  • Circulate medical messaging from KOLs among the KOL network during pre-launch to ensure it percolates to the next tier including community opinion leaders (COLs) and local healthcare practitioners (HCPs)
  • Gain an overview of the “Pyramid of Influence” concept that increases participants’ understanding of how information flows among HCPs from all tiers, and how pharma can leverage this information to achieve a successful product launch
  • Learn how this concept helps medical and commercial teams work together prior to launch, not only to achieve effective medical communications but also to later optimize the field sales force
Speaker

Badal Shah
Managing Director, Health Analytics
QPHARMA

Presentation

The economic impact of value on different payment models

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Overview of main payment mechanisms
  • Basics of hospital financing
  • Activity-based payments: DRG
  • Value-based payments
  • Shift to value: is it happening now?
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Value-Based Reimbursement: including a new procedure in the Brazilian Public Healthcare System (SUS)

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Quantification of the unmet need for SUS.
  • Development of cost-effectiveness and budget impact analyses.
  • Potential scenarios for SUS with inclusion of technology.
  • Project results and next steps.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Access & Value of healthcare innovation in Latin America

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Latin America
Availability: FREE
  • Evolution of cost-containment tools in Latin America: reference pricing, health technology assessment and harnessing competition through procurement

  • Rise of health technology assessment as a decision-making tool in Latin America and implications for manufacturers looking to demonstrate the value of their innovation

  • Designing successful market access strategies that meet growing payer expectations 

Speakers

Miguel Martin de Bustamante
Principal
CBPartners, USA
 

Valeria Boers Trilles
Manager
CBPartners, USA

Presentation

Changing Trends in Real World Evidence

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Payer expectations.
  • The regulatory landscape.
  • Access to data.
  • The Increasing voice of the patient.
  • What is in store for sponsor-CRO partnerships?
Speaker

Noolie Gregory
Exec Dir, Client Engagement
Syneos Health, UK

Presentation

Early Access Programs – as a valuable component of market access and launch strategy

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Clinical
Availability: FREE
  • Understand how these programs have been used extensively by pharma companies to address unmet medical need, but have broader market access benefits including another source of real world data.  This session will help people understand the basics about EAPs, the current landscape and industry trends around EAPs, and the types of data that various companies are capturing.  A case study will be provided.
Speaker

Kieron Lewis
Global Business Development Director
Clinigen, UK

Presentation

Facilitating innovative pricing, value based reimbursement and personalised medicine using revolutionary blockchain technology

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, IT & Big Data
Availability: FREE
  • A new paradigm: Introduction to blockchain technology and its applications in healthcare
  • Digipharm: overcoming barriers to innovative pricing solutions and value based reimbursement
  • Innovative evidence generation and the impact on pricing & reimbursement
Speaker

Ahmed Abdulla
CEO
Digipharm, Switzerland

Presentation

Market access for (very high cost) rare disease or transformative therapies: changing our mindset

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Orphan Drugs
Availability: FREE
  • Aggregated budget impact of these therapies
  • Funding and contracting approaches
  • Value-based thinking
Speakers

Akshay Kumar
Principal Consultant
Pope Woodhead, UK

Eugenia Priedane
Senior Consultant
Pope Woodhead, UK

Presentation

Adaptive, Umbrella and Basket studies - What are they, Why are they needed, and how will payers receive them?

Related topics: Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE

There is a well-recognized long-standing decline in R&D productivity in the pharmaceutical industry which has driven exploration of new approaches to the clinical development of pharmaceuticals.  These include innovative randomized controlled trial designs, including adaptive, umbrella, and basket studies. Adaptive trials, perhaps the best established of these, have already been the subject of guidance documents by both the European Medicines Agency and Food and Drug Administration. However, in many markets it is the reimbursement hurdle (rather than the regulatory hurdle) that is proving the major barrier to overcome in order to enable patient access. Therefore, payer perceptions on such innovative trial designs will be key to informing pharmaceutical company utilization of such approaches. This presentation will provide an overview of these innovative new designs and present payer perspectives on the benefits and challenges posed by conducting reimbursement assessments on data coming from these trial designs, based on discussions with a German and UK payer.

Speakers

Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting

 

Richard Macaulay
Principal Consultant, (Pricing and Market Access)
Parexel, UK

Presentation

Real world evidence: Opportunities and challenges with registry data

Related topics: Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE

- Real world data solutions in the post-marketing world: the multiple sclerosis experience

- Introduction to the MSBase international registry

- Methods for separating drug signals from bias in observational data

- Pharma / disease registry collaborations in comparative effectiveness analyses

- Big data: Big MS and beyond

Speaker

Tim Spelman
Senior Scientist
Synergus

Presentation

Leading MSLs to the best of their potential

Related topics: Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
  • Internal training
  • Engagement tool
  • Keeping the conversation going
Speakers

Annie Rankin
Client Partnerships Lead
Succinct Medical Communications

Gavin Kenny
Account Director
Succinct Medical Communications

Presentation

The power of consistent communication with HCPs and patients

Related topics: Medical Affairs & Stakeholder Engagement, Patient-Centricity & Care
Availability: FREE
  • Keeping consistency in communications with both HCPs and patients to maximise high quality patient-HCP conversations
Speakers

Katie Corbin
Managing Director
Succinct Medical Communications

Richard Jones
Patient Services Director
The Earthworks (an OPEN Health Company)

Presentation

Multichannel strategy and behavioural science: perfect partners for smarter communications

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Appreciate the importance of understanding human behaviour in designing effective and affective medical communications
  • Recognise the synergistic benefits of bringing behavioural insights and multichannel strategy together for smarter, more targeted communications
  • Challenge your communications strategy: not doing things ‘because we’ve always done it this way’, looking critically at the end goals, the behavioural context and barriers, and designing a smart multichannel strategy
Speakers

Louise Picken
Senior Scientific Director
Complete HealthVizion

Robert Poole
Director of Scientific Services
Complete HealthVizion

Presentation

The art and science of designing a RWD project

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  •  The hidden link between product strategy and scientific approach
  • Challenges and opportunities in dealing with many stakeholders
  • Prioritizing multiple interests in one “finer” research question
  • A project design workflow for clinical research with RWD
Speaker

Giovanni Fiori
Managing & Scientific Director
MediNeos

Presentation

Promoting the patient voice in evidence generation and global market access planning

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Patient-Centricity & Care
Availability: FREE
  • Regulator and payer perspectives on patient-centric data in decision making.
  • Highly successful strategies for leveraging the patient voice in RWE research.
Speakers

Leanne Larson
Corporate VP, Observational Research
PAREXEL

Richard Macaulay
Principal Consultant, (Pricing and Market Access)
Parexel, UK

Presentation

The changing trends in real-world Evidence

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker

Maryna Kolochavina
Project Director, Real World & Late Phase
Syneos Health

Presentation

Increasing the efficiency of your Medical Affairs Team: The Silent Time Killer of Copy Review

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Case Study: How outsourcing can unburden your team to focus on value-adding relationships
Speaker

Tessa Pugh
Director
PharmaReview, UK

Presentation

From NPS to an actionable customer centric listening program: A global approach

Related topics: MedTech, Commercial
Availability: FREE
  • Moving beyond NPS
  • Engaging a global team to get local customer insight
  • Maintaining the focus on the customer
  • Driving the global process forward.
  • It’s not just the numbers: Tell the story of the customer
Speakers

Shane West
VP Client Relations
Cetas Healthcare Insights, Norway

Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, India

Presentation

Opportunities for digital technologies and services to drive value and access for Medtech

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • What does the new world of medtech and digital health look like?
  • How can digital technologies and services enhance the value of devices in a meaningful way to payers?
  • How will these innovative solutions be regulated and reimbursed?
Speaker

Anne Smart
Managing Director
ClearView Healthcare Partners, USA

Presentation

Create customised digital experiences for payers and HCPs

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE

Explore how new digital technologies enhance your customer interactions and deliver real commercial benefit 

  • Understand how your customers’ needs have changed
  • Learn how digital technology enables you to respond to these new challenges
  • Explore how virtual engagement technologies create new opportunities
  • See real-life examples of how digital solutions have transformed customer relationships
  • Bringing it all together: learn how to use the data to extend commercial opportunities
Speaker

Lars U Diemer
Chief Executive Officer
Agnitio, Denmark

Presentation

The best buyer experience wins - How to use digital to leave a mark with the empowered buyer

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Empowered buyer teams force Marketing & Sales to step up their game
  • Marketing can support sales teams to become more solution-centric
  • Sales teams can go beyond the expected and impact the modern day buyer
  • Ceterix, bioMérieux and ARGEN use sales enablement technology to step change Marketing and Sales alignment and grow sales productivity.
Speaker

Orhan Dayioglu
Sales Transformation Leader
Showpad, Germany

Presentation

The Journey of a Top 20 MedTech Sales Enablement Project

Related topics: MedTech, Commercial
Availability: FREE
  • Situation before the project start
  • Evaluation process and piloting
  • Implementation approach
  • Outlook for the future
Speaker

Arik Brückner
Commercial Director
Pitcher AG

Presentation

Elevating the market access competency to maximize business impact

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Becoming an integral partner in strategic business decision making
  • Organizing the competency in today’s value-based healthcare (VBHC) environment
  • Case studies
Speaker

Rob Wenthold
Vice President
Boston Healthcare

Presentation

Value-Based Selling: are we there yet?

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • What is Value and how to quantify it?
  • “Doctors love my product, but I still cannot sell it” - an evolving balance of power
  • Do I need Reimbursement? What are the risks?
  • “Your product is too expensive”: fact or misperception?
  • Case example: from “easy-to-use” to “cost-saving”
  • Practical recommendations for Value-Based Sales
Speaker

Ben Modley
Director of European Operations
Value Connected, Germany

Presentation

Successful marketing claims in current regulatory environment

Related topics: MedTech, Commercial, Regulations & Ethics
Availability: FREE
  • Current and future regulatory environment
  • How is the industry geared to address these changes?
  • What are the constructs of an ideal marketing claims strategy?
  • What are the gold standard practices for marketing claims?
  • How to deal with unsuccessful claims?
Speakers

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Singapore

Claus Schaffrath
Consultant & Founder
Cetas Healthcare & MD squared, The Netherlands

Presentation

Transforming to a Customer Centric Go-to- Market Model in Med Tech

Related topics: MedTech, Commercial, Patient-Centricity & Care
Availability: FREE
  • Understanding the shifting buyer universe.
  • Defining the organisation of the future.
  • Key challenges & opportunities when transforming your business around the customer.
  • Outlining different transformation pathways depending on your organisational imperative & operational maturity.
Speakers

Mark Taylor
Director, EMEA
Blackdot, UK

Linton Chalmers
EMEA Practice Lead, Capability & People Advisory
Blackdot, UK

Presentation

Challenges and opportunities for successful Real World Evidence strategy

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Nourdine Bouzekri
Principal Industry Consultant
SAS, France

Presentation

Putting the patient/citizen into the driving seat

Related topics: Pharmaceutical/Biotech, MedTech, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
  • The key elements to leverage the potential of electronic health care data: Where is the trust?
  • Regulations which might support it: GDPR and other regulations
  • Who are the partners/stakeholders and their major responsibilities?
  • Democratization of the analytics and data: Patients view and the citizen handle it?
  • Ethical consideration about not being in a position using the data: Another view or how interests might need a balance and who might be in charge?
Speaker

Peter Grolimund
Sr. Life Science Industry Consultant
ThinkBig Analytics (a Teradata company)

Presentation

Artificial intelligence for drug discovery, biomarker development and aging research

Related topics: Pharmaceutical/Biotech, MedTech, Diagnostics, IT & Big Data, Discovery & R&D Innovation
Availability: FREE
Speaker

Alex Aliper
President
Insilico Medicine

Presentation

The Sentient Enterprise or ‘Sentient’ healthcare as a vision in using data

Related topics: Pharmaceutical/Biotech, MedTech, Market Access & HEOR, Real-World Evidence & Late-Phase Research, IT & Big Data, Discovery & R&D Innovation
Availability: FREE
  • Another approach to personalised medicine and outcome-based reimbursement: The sentient healthcare enterprise.
  • The technology and trends to get there.
  • The data and analytical democracy of all stakeholders.
  • The major challenges and how to handle those in order to manage the healthcare costs.
  • Examples from other industries.
Speaker

Stephen A. Brobst
CTO
Teradata Corporation

Presentation

Enabling economic selling

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • What is the role of market access in economic selling?
  • The challenge of quantifying value.
  • Building effective tools and training methods.
  • Partnering with commercial teams.
  • Case studies: Selling value in the UK and Germany.
Speaker

Ernesto M. Nogueira
Managing Director
Value Connected, Netherlands

Register to view both free videos and browse premium content (and event documentation).

1227
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!